Point-Counter Point: Treating Corneal Haze with 0.8 mg/mL Topical Losartan
Year: 2024
Type: article
Source: Clinical Insights in Eyecare
DOI: 10.66574/001c.126743
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7160180856
